Selskabets formål er at drive handel med farmaceutiske produkter, hospitalsprodukter og diagnostik samt udvikle, producere og markedsføre teknologi og know-how i forbindelse hermed. Selskabet kan derudover yde tjenesteydelser og assistance, herunder af administrativ, driftmæssig, finansiel, forretningsmæssig, videnskabelig eller industriel karakter, i tilknytning til selskabets formål til tredjemænd, aktionærer, datterselskaber eller tilknyttede selkaber.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 336.9 mio. | 11.1 mio. | 206 mio. | 73 mio. | 48 | |
CVR: 34462828
Secondary names: Allergan Aesthetics A/S
Compared to 288 companies in Engroshandel med læge- og hospitalsartikler
Comparison is based on industry median values
Companies in the same industry and area
CVR 44476533
CVR 33860463
CVR 35234748
CVR 39762560
CVR 39807114
ABBVIE A/S demonstrates a solid financial health with a consistent revenue growth trajectory, increasing from 183.9 million DKK in 2020 to 336.9 million DKK in 2024. However, profit margins have shown some volatility, with a peak profit of 13.7 million DKK in 2023, followed by a decline to 11.1 million DKK in 2024. The company's equity has decreased significantly from 196.2 million DKK in 2022 to 72.9 million DKK in 2024, raising concerns about its long-term financial stability. Positioned within the wholesale trade of medical and hospital supplies, ABBVIE A/S is navigating a competitive landscape, and its ability to maintain profitability amidst fluctuating equity will be crucial for future growth.
AI-generated summary
companydata.dk